Executive Summary
Prophylactic HIV Drugs Market from Consainsights analyses the Prophylactic HIV Drugs Market in the Technology &
Media industry over the forecast period to 2026.
Prophylactic HIV Drugs research report from Consainsights outlines the detailed strategic analysis, trends,
market
opportunities, growth prospects, industry and market challenges and sustainable solutions to
sustain in the
competitive environment.
Prophylactic HIV Drugs segmentation includes Drug, Dosage Form and Geography.
All segmentations encompasses the key innovations and
micro & macro trends, companies/manufacturers operating in this space along with their usage
and penetration
with respect to the wide range of End Users. Additionally, market sizing information along with
the key factors
such as market drivers, restraints, opportunities and challenges which are likely to be
influencing the market
growth are outlined in this report.
Based on the Drug, the Prophylactic HIV Drugs Market analysis covers Emtricitabine, Other Drugs, Tenofovir.
Based on the Dosage Form, the Prophylactic HIV Drugs Market analysis covers Oral, Topical.
Key companies operating in the market include ViiV Healthcare Group of Companies, Merck & Co. Inc., Cipla Inc., Auro Pharma Inc., Genentech Inc., Pfizer Inc., GalaxoSmithKline PLC, Gilead Sciences Inc., Johnson & Johnson Health Care Systems Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, APOTEX INC., Mylan NV, AbbVie, Teva Pharmaceutical Industries Ltd and so on. This report
covers the detailed analysis of the company profiles
such as business segments, product portfolio, key brand insights and growth strategies adopted,
company SWOT and
Strategy analysis along with the financial analysis and analyst insights on the key companies
operating in this
market.
Moreover, the competitive analysis includes the companies deals such as Mergers, Acquisitions,
Partnerships and
so on along with the expansion areas focusing on the additional geographies, future insights for
success and
market share analysis. Major players strategies include the launch of the innovative product
lines along with
the emphasis on the partnerships and acquisitions to standardize their market share in the
market space.
Market Research methodology includes the triangulation of the data from the data sources such as
Primary Market
Research approach and Secondary Market Research Approach along with the data from the trade
bodies and industry
standard publications and data sources. Primary inputs from the industry experts and the market
respondents from
the respective industries to obtain very critical information to assess the future growth
prospects of the
market. The final data is triangulated and thoroughly validated considering all the data sources
using the
bottom-up and the top-down approaches to estimate the market sizing of the individual segments.
Report Metric
|
Details
|
Market size available for years
|
2012-2027
|
Base year considered
|
2021
|
Forecast period
|
2022-2027
|
Forecast units
|
Value (USD Billion)
|
Segments covered
|
Drug, Dosage Form
|
Geographies covered
|
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
|
Companies Covered
|
ViiV Healthcare Group of Companies, Merck & Co. Inc., Cipla Inc., Auro Pharma Inc., Genentech Inc., Pfizer Inc., GalaxoSmithKline PLC, Gilead Sciences Inc., Johnson & Johnson Health Care Systems Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, APOTEX INC., Mylan NV, AbbVie, Teva Pharmaceutical Industries Ltd
|
List of Figures & Tables
List of Figures
Figure: Global Prophylactic HIV Drugs Market: Structure
Figure: Global Prophylactic HIV Drugs Market: Value Chain Analysis
Figure: Global Prophylactic HIV Drugs Market: Porter's Five Forces Model
Figure: Global Prophylactic HIV Drugs Market: Market Dynamics
Figure: Global Prophylactic HIV Drugs Market, By Prophylactic HIV Drugs, 2022-2027 (USD Million)
Figure: North America Prophylactic HIV Drugs Market, By Prophylactic HIV Drugs, 2022-2027 (USD Million)
Figure: Europe Prophylactic HIV Drugs Market, By Prophylactic HIV Drugs, 2022-2027 (USD Million)
Figure: Asia-Pacific Prophylactic HIV Drugs Market, By Prophylactic HIV Drugs, 2022-2027 (USD Million)
Figure: Latin America Prophylactic HIV Drugs Market, By Prophylactic HIV Drugs, 2022-2027 (USD Million)
Figure: Middle East & Africa Prophylactic HIV Drugs Market, By Prophylactic HIV Drugs, 2022-2027 (USD Million)
Figure: Global Prophylactic HIV Drugs Market, By Prophylactic HIV Drugs, 2022-2027 (USD Million)
Figure: North America Prophylactic HIV Drugs Market, By Prophylactic HIV Drugs, 2022-2027 (USD Million)
Figure: Europe Prophylactic HIV Drugs Market, By Prophylactic HIV Drugs, 2022-2027 (USD Million)
Figure: Asia-Pacific Prophylactic HIV Drugs Market, By Prophylactic HIV Drugs, 2022-2027 (USD Million)
Figure: Latin America Prophylactic HIV Drugs Market, By Prophylactic HIV Drugs, 2022-2027 (USD Million)
Figure: Middle East & Africa Prophylactic HIV Drugs Market, By Prophylactic HIV Drugs, 2022-2027 (USD Million)
List of Tables
Table: Global Prophylactic HIV Drugs Market, By Drug, 2017-2026 (USD Million)
Table: North America Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: United States Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: Canada Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: Europe Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: Germany Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: United Kingdom Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: France Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: Spain Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: Russia Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: Italy Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: Rest of Europe Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: Asia-Pacific Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: China Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: Japan Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: India Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: Southeast Asia Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: Australia & New Zealand Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: Rest of Asia-Pacific Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: Latin America Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: Brazil Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: Argentina Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: Mexico Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: Colombia Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: Rest of Latin America Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: Middle East & Africa Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: Middle East Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: Africa Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: Rest of Middle East & Africa Prophylactic HIV Drugs Market, By Drug, 2022-2027 (USD Million)
Table: Global Prophylactic HIV Drugs Market, By Dosage Form, 2017-2026 (USD Million)
Table: North America Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)
Table: United States Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)
Table: Canada Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)
Table: Europe Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)
Table: Germany Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)
Table: United Kingdom Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)
Table: France Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)
Table: Spain Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)
Table: Russia Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)
Table: Italy Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)
Table: Rest of Europe Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)
Table: Asia-Pacific Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)
Table: China Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)
Table: Japan Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)
Table: India Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)
Table: Southeast Asia Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)
Table: Australia & New Zealand Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)
Table: Rest of Asia-Pacific Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)
Table: Latin America Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)
Table: Brazil Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)
Table: Argentina Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)
Table: Mexico Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)
Table: Colombia Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)
Table: Rest of Latin America Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)
Table: Middle East & Africa Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)
Table: Middle East Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)
Table: Africa Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)
Table: Rest of Middle East & Africa Prophylactic HIV Drugs Market, By Dosage Form, 2022-2027 (USD Million)